Trastornos del lenguaje y epilepsia

1. Pozo Alonso A. Epilepsia. En: Pediatría: Diagnóstico y tratamiento. 3rd ed. La Habana: Editorial Ciencias Médicas; 2016. p. 275-80.

2. Myers KA, Ingrid Scheffer IE. GRIN2A-Related Speech Disorders and Epilepsy. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2018 [citado: 24/04/2018]. Disponible en: https://preview.ncbi.nlm.nih.gov/books/NBK385627/

3. Pierson TM, Yuan H, Marsh ED, Fuentes-Fajardo K, Adams DR, Markello T, et al. GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine. Ann Clin Transl Neurol. 2014;1(3):190-8.

4. Cohen BH, Chinnery PF, Copeland WC. POLG-Related Disorders. En: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2018 [citado: 26/04/2018]. Disponible en: https://preiew.ncbi.nlm.nih.gov/pubmed/20301791

5. Mucha BE, Hennekam RCM, Sisodiya S, Campeau PM. TBC1D24-Related Disorders. En: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2018 [citado: 8/5/2018]. Disponible en: https://preiew.ncbi.nlm.nih.gov/pubmed/25719194

6. Besenyei M, Varga E, Fekete I. EEG background activity is abnormal in the temporal and inferior parietal cortex in benign rolandic epilepsy of childhood: a LORETA study. Epilepsy Res. 2012;98(1):44-9.

7. Pesantez-Rios G, Martinez-Bermejo A, Pesantez-Cuesta G. Neuropsychological alterations are frequent in rolandic epilepsy and its atypical developments. Rev Neurol. 2016;63(3):125-9.

8. Van Klink NE, van 'tKlooster MA, Leijten FS, Jacobs J, Braun KP, Zijlmans M. Ripples on rolandic spikes: a marker of epilepsy severity. Epilepsia. 2016;57(7):1179-89.

9. Carvill GL, Regan BM, Yendle SC, O'Roak BJ, Lozovaya N, Bruneau N, et al. GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nat Genet. 2013;45(9):1073-6.

10. Liu YT, Nian FS, Chou WJ. PRRT2 mutations lead to neuronal dysfunction and neurodevelopmental defects. Oncotarget. 2016;7(26):39184-96.

11. Djémié T, Weckhuysen S, Holmgren P, Hardies K, Van Dyck T, HendrickxR, et al. PRRT2 mutations: exploring the phenotypical boundaries. J Neurol Neurosurg Psychiatry [Internet]. 2014 [citado: 22/05/2018];85:462-5. Disponible en: http://dx.doi.org/10.1136/jnnp-2013-305122

12. Reinthaler EM, Lal D, Jurkowski W. Analysis of ELP4, SRPX2, and interacting genes in typical and atypical rolandic epilepsy. Epilepsia. 2014;55(8):83-93.

13. Allen NM, Conroy J, Deonna T. Atypical benign partial epilepsy of childhood with acquired neurocognitive, lexical semantic and autistic spectrum disorder. Epilepsy Behav Case Rep. 2016;6:42-8.

14. Dimassi S, Labalme A, Lesca G. A subset of genomic alterations detected in rolandic epilepsies contains candidate or known epilepsy genes including GRIN2A and PRRT2. Epilepsia. 2014;55(2):370-8.

15. Riccio CA, Vidrine SM, Cohen MJ, Acosta-Cotte D, Park Y. Neurocognitive and behavioral profiles of children with Landau-Kleffner syndrome. App Neuropsychol Child. 2016;6(4):1-10.

16. Caraballo RH, Veggiotti P, Kaltenmeier MC. Encephalopathy with status epilepticus during sleep or continuous spikes and waves during slow sleep syndrome: a multicenter, long-term follow-up study of 117 patients. Epilepsy Res. 2013;105(1-2):164-73.

17. Tassinari CA, Rubboli G. Cognition and paroxysmal EEG activities: from a single spike to electrical status epilepticus during sleep. Epilepsia. 2006;47(Suppl 2):40-3.

18. García García RJ. Epilepsia y comorbilidad. En: Morales Chacón L y Kochen S. Epilepsias en el primer nivel de atención de salud. Buenos Aires: OPS-ILAE Cuba; 2017. p. 121-34.

19. Sung Koo Ki. Recent update of autism spectrum disorders. Korean J Pediatr. 2015;58(1):8-14.

20. Guglielmi L, Servettini I, Caramia M, Catacuzzeno L, Franciolini F, Cristina D’Adamo M, et al. Update on the implication of potassium channels in autism: K+ channel autism spectrum disorder. Front Cell Neurosci. 2015;9(34):1-14.

21. Brooks-Kayal A. Epilepsy and autism spectrum disorders: Are there common developmental mechanisms? Brain Dev. 2010;32(9):731-8.

22. Talat MA, Ahmed A, Mohammed L. Serum levels of zinc and copper in epileptic children during longterm therapy with anticonvulsants. Neurosciences. 2015;20(4):341-5.

23. Campistol J. Orientación diagnóstica de las enfermedades neurometabólicas basada en la clínica, estudios metabólicos y neurometabólicos. Medicina (Buenos Aires). 2013;73(Supl. I):55-62.

24. Patil SA, Maegawa GHB. Developing therapeutic approaches for metachromatic leukodystrophy. Drug Des Devel Ther. 2013;7:729-45.

25. Hilgers A, Schaefer M. Systematic Adverse Drug Reaction Monitoring of Patients Under Newer Antiepileptic Drugs Using Routine Clinical Data of Inpatients. Drugs - Real World Outcomes. 2016;3(2):209-21.

26. García Peñas JJ, Fournier del Castillo MC, Domínguez Carral J. Epilepsia y cognición: el papel de los fármacos antiepilépticos. Rev Neurol. 2014;58 (Supl 1):537-42.

27. Ijff DN, Aldenbamp AP. Cognitive side-effects on antiepileptic drugs in children. Handb Clin Neurol. 2013;111:708-18.

28. Berberian AP, Hopker C, Mazzarotto I, Jenane Cunha J. Aspects of Oral Language, Speech, and Written Language in Subjects with Temporal Lobe Epilepsy of Difficult Control. Int Arch Otorhinolaryngol. 2015;19:302-8.